Healthcare -
Biotechnology - NASDAQ - US
$ 25.32
-0.0789 %
$ 298 M
Market Cap
25.29
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
-0.00%
Net Income
Estimate
-0.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
XOMA Corporation
XOMAP has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart XOMAP
EBIT FORECAST
EBIT Forecast Chart XOMAP
NET INCOME FORECAST
Net Income Chart XOMAP